Dexmedetomidine provides cortical neuroprotection: Impact on anaesthetic-induced neuroapoptosis in the rat developing brain

Acta Anaesthesiologica Scandinavica

Volumn 54, Issue 6, 2010, Pages 710-716

  Sanders, R D ^a   Sun, P ^a   Patel, S ^a   Li, M ^b   Maze, M ^a   Ma, D ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DEXMEDETOMIDINE; ISOFLURANE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; ANDROSTANE DERIVATIVE; BIOLOGICAL MARKER; INHALATION ANESTHETIC AGENT; NERVE PROTEIN; NEUROPROTECTIVE AGENT; STAUROSPORINE; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INJURY; CELL SURVIVAL; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; CELL CULTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; GROWTH, DEVELOPMENT AND AGING; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT; TOXICITY;

ANDROSTADIENES; ANESTHETICS, INHALATION; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELLS, CULTURED; CEREBRAL CORTEX; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ISOFLURANE; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; STAUROSPORINE;

EID: 77953163439     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.02177.x     Document Type: Article

References (17)

1. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003 23 : 876 882.
2. Hansen HH, Briem T, Dzietko M, Sifringer M, Voss A, Rzeski W, Zdzisinska B, Thor F, Heumann R, Stepulak A, Bittigau P, Ikonomidou C. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 2004 16 : 440 453.
3. Lu LX, Yon JH, Carter LB, Jevtovic-Todorovic V. General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 2006 11 : 1603 1615.
4. Ma D, Williamson P, Januszewski A, Nogaro MC, Hossain M, Ong LP, Shu Y, Franks NP, Maze M. Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Anesthesiology 2007 106 : 746 753.
5. Sanders RD, Ju X, Shu Y, Januszweski A, Halder S, Fidalgo A, Sun P, Hossain M, Ma D, Maze M. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 2009 110 : 1077 1085.
6. Sanders RD, Ma D, Brooks P, Maze M. Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection and neurotoxicity. Br J Anaesth 2008 101 : 597 609.
7. Slikker W Jr., Zou X, Hotchkiss CE, Divine RL, Sadovova N, Twaddle NC, Doerge DR, Scallet AC, Patterson TA, Hanig JP, Paule MG, Wang C. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 2007 98 : 145 158.
8. 2A-adrenoceptor subtype. Eur J Pharmacol 2004 502 : 87 97.
9. Koh JY, Wie MB, Gwag BJ, Sensi SL, Canzoniero LM, Demaro J, Csernansky C, Choi DW. Staurosporine-induced neuronal apoptosis. Exp Neurol 1995 135 : 153 159.
10. Goswami R, Dawson SA, Dawson G. Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons. J Neurochem 1998 70 : 1376 1382.
11. Rong R, Ahn JY, Huang H, Nagata E, Kalman D, Kapp JA, Tu J, Worley PF, Snyder SH, Ye K. P I3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat Neurosci 2003 6 : 1153 1161.
12. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009 460 : 232 236.
13. Straiko MM, Young C, Cattano D, Creeley CE, Wang H, Smith DJ, Johnson SA, Li ES, Olney JW. Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology 2009 110 : 862 868.
14. Dahmani S, Paris A, Jannier V, Hein L, Rouelle D, Scholz J, Gressens P, Mantz J. Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor- independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology 2008 108 : 457 466.
15. Engelhard K, Werner C, Eberspächer E, Bachl M, Blobner M, Hildt E, Hutzler P, Kochs E. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003 96 : 524 531.
16. 2-adrenergic agonists. Anesthesiology 2000 93 : 1345 1349.
17. Sanders RD, Maze M. Alpha2-adrenoceptor agonists. Curr Opin Investig Drugs 2007 8 : 25 33.